Keiji Hasumi

Jitsubo Co., Ltd. researches, develops, and produces peptides. It operates as a peptide development company that provides solutions to patients using their proprietary technologies for manufacturing and engineering peptides. The firm specializes in peptide synthesis, which enables users to modify amino acid sequence for the creation of physical, chemical, and pharmacological properties. It also engages in development of peptide pharmaceuticals, licensing regarding active ingredient manufacturing technology for peptides, and peptide drug discovery research. The company was founded by Yusuke Kohno and Kazuhiro Chiba in 2000 and is headquartered in Tokyo, Japan.

Part of Thermo Fisher Scientific, Inc., PPD-SNBL KK is a Japanese company that provides clinical research services. The company is based in Tokyo, Japan.

Part of Mitsubishi Corp., Mitsubishi Corporation LT USA is a company that engages in the distribution of electronics, fuels, metals, and chemicals. The company is based in Schaumburg, IL.

Part of Wave Life Sciences Ltd., Wave Life Sciences USA, Inc. is a company that provides nucleic acid therapeutics. The company is based in Cambridge, MA. The company was founded in 2012 by Gregory L. Verdine, Takeshi Wada. The CEO is Paul B. Bolno.

Epson is a global leader in imaging products including printers, 3LCD projectors and small- and medium-sized LCDs. With an innovative and creative culture, Epson is dedicated to exceeding the vision and expectations of customers worldwide with products known for their superior quality, functionality, compactness and energy efficiency. Epson is a network of 102,025 employees in 120 companies around the world, and is proud of its ongoing contributions to the global environment and to the communities in which it is located. Led by the Japan-based Seiko Epson Corp., the Group had consolidated sales of 1549.5 billion yen in fiscal 2005.

Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan.

Part of JSR Corp., Beijing B & m Biotech Co., Ltd. is a company that provides medical services and tools. The company is based in Beijing, China.

Medipolis Medical Research Institute offers proton beam cancer treatment. The company was founded on March 2006 and is headquartered in Ibusuki, Japan.

Abmaxis Inc. develops pharmaceutical drugs. The company discovers and optimizes monoclonal antibody (mAb) products for human therapeutics and diagnostics. It has developed antibody engineering technology platform, Abmaxis in-silico Immunization (AISIM TM), which they are used for building an internal product pipeline and collaboration with global biotech and pharmaceutical partners. The company was founded in 2000 and is located in Santa Clara, CA.

Part of Arte Salon Holdings, Inc., Ash Co., Ltd. operates a chain of salons and retails beauty materials and cosmetics through its subsidiary. The company is based in Yokohama, Japan.

Part of Arte Salon Holdings, Inc., Diamond Eyes KK is a salon that specializes in eyelash extensions and other related services such as design rash lift and parisien nurash lift. The company is based in Tokyo, Japan and all of its salons are conveniently located near train stations. The employees are licensed hairdressers and use special skills and materials to ensure the safety and security of their clients. Diamond Eyes KK was acquired by Arte Salon Holdings, Inc. from Ruruter KK on December 30, 2014 for $1.04 million.

CFJ KK engages in the management of hair salon. The company is headquartered in Yokohama, Japan.

Advanced Science & Technology Enterprise Corp. (ASTEC) is an independent Japanese venture capital firm which was established in 2001 as a 'Kabushiki Kaisha' by Takuro Wakabayashi and a group of professors at the University of Tokyo. The idea was to create a very early-stage venture capital firm to provide support to Japanese technology start-ups with innovative products and services. Based in Tokyo, the firm manages the ASTEC Technology Incubation Fund, backed primarily by institutional investors. They also provide services to help Japanese universities manage collaborative research and consortiums and collaborate with Technology Licensing Organizations to help with commercialization efforts.

Advanced Photonics, Inc. is a holding company that designs, develops, and manufactures optical circuit boards. Its products encompass photoelectric conversion modules and optical printed circuit boards. The company was founded by Makotoon Shigematsu on March 15, 2006 and is headquartered in Tokyo, Japan.

Dept Corp. engages in the development of electronic devices. It produces self-assembled microscopial structures and thin-film coatings used by liquid-crystal display manufacturers. The company was founded by Takashi Ueno on August 16, 2002 and is headquartered in Tokyo, Japan.

BioMedCore, Inc. provides biotechnology development services. It specializes in the research, development, production, and marketing of liposomal technologies. It also develops treatments for cancer, posterior segment inflammatory diseases, and myocardial reperfusion injury. The company was founded by Yuichiro Satoh and Norio Naruse in December 2005 and is headquartered in Yokohama, Japan.

REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan.

Part of Arte Salon Holdings, Inc., Style Designer, Inc. operates a beauty salon franchise chain. The company is based in Tokyo, Japan. Style Designer was acquired by Arte Salon Holdings, Inc. on January 06, 2009.